These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17286238)

  • 1. Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients.
    Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):58-61. PubMed ID: 17286238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.
    Papanas N; Papatheodorou K; Christakidis D; Papazoglou D; Giassakis G; Piperidou H; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):195-8. PubMed ID: 15891953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.
    Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
    J Diabetes Complications; 2007; 21(6):353-8. PubMed ID: 17967706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study on the use of the indicator test Neuropad® for the early diagnosis of peripheral neuropathy in type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Kotsiou S; Maltezos E
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):122-5. PubMed ID: 20690070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication.
    Papanas N; Papatheodorou K; Papazoglou D; Christakidis D; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):577-81. PubMed ID: 16320155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Mendivil CO; Kattah W; Orduz A; Tique C; Cárdenas JL; Patiño JE
    J Diabetes Complications; 2016; 30(1):93-8. PubMed ID: 26525688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical diabetic neuropathy: a common complication in Saudi diabetics.
    Akbar DH; Mira SA; Zawawi TH; Malibary HM
    Saudi Med J; 2000 May; 21(5):433-7. PubMed ID: 11500676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy.
    Spallone V; Morganti R; Siampli M; Fedele T; D'Amato C; Cacciotti L; Maiello MR
    Diabet Med; 2009 Jul; 26(7):686-92. PubMed ID: 19573117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Neuropad test in the screening of peripheral neuropathy in diabetic patients].
    Freitas C; Carvalho A; Melo-Rocha G; Amaral C; Pinto S; Guimarães R; Neto H; Suascun J; Muras J; Gonçalves I; Martins J; Dores J; Carvalho R; Borges F
    Acta Med Port; 2009; 22(6):729-34. PubMed ID: 20350454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement.
    Zografou I; Iliadis F; Sambanis C; Didangelos T
    Curr Vasc Pharmacol; 2020; 18(5):517-522. PubMed ID: 31340739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
    Kamenov ZA; Petrova JJ; Christov VG
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The indicator test Neuropad in the assessment of small and overall nerve fibre dysfunction in patients with type 2 diabetes: a large multicentre study.
    Manes C; Papanas N; Exiara T; Katsiki N; Papantoniou S; Kirlaki E; Tsotoulidis S; Kefalogiannis N; Maltezos E
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):195-9. PubMed ID: 24643697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new indicator test (Neuropad): a valuable diagnostic tool for small-fiber impairment in patients with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Christakidis D; Monastiriotis C; Maltezos E
    Diabetes Educ; 2007; 33(2):257-8, 260, 262 passim. PubMed ID: 17426301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictors for diabetic neuropathy according to applied criteria of its diagnosis].
    Gryz EA; Szermer P; Galicka-Latała D; Sieradzki J; Szczudlik A
    Przegl Lek; 2002; 59(11):881-4. PubMed ID: 12715713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.
    Gin H; Baudoin R; Raffaitin CH; Rigalleau V; Gonzalez C
    Diabetes Metab; 2011 Dec; 37(6):527-32. PubMed ID: 21715211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey.
    Ziegler D; Papanas N; Rathmann W; Heier M; Scheer M; Meisinger C;
    Diabetes Metab Res Rev; 2012 Nov; 28(8):692-7. PubMed ID: 22949335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of obesity on the assessment of diabetic peripheral neuropathy: a comparison of Michigan patient version test and Michigan physical assessment.
    Boyraz O; Saracoglu M
    Diabetes Res Clin Pract; 2010 Dec; 90(3):256-60. PubMed ID: 20943282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot temperature in type 2 diabetic patients with or without peripheral neuropathy.
    Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):44-7. PubMed ID: 18726865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes.
    Tentolouris N; Achtsidis V; Marinou K; Katsilambros N
    Diabetes Care; 2008 Feb; 31(2):236-7. PubMed ID: 18025406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.